课题基金 / 基金详情

Program Leaders

Program Leaders
项目负责人
批准号:
8733554
负责人:
MARY M. ZUTTER
金额:
$7.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2015-08-31

项目摘要

项目成果

MARY M. ZUTTER的其他基金

相似基金

相关文献

中文摘要
翻译
研究方案领导人委员会-研究方案领导人委员会每月第一个星期四开会,讨论与维也纳国际中心内的研究机会和需要有关的问题。会议由基础科学研究计划主任和副主任共同主持。其他成员包括所有研究 项目负责人和联合负责人,副主任,临床科学研究项目副主任,预防,控制和人口研究副主任,共享资源副主任,CCSG行政副主任和名誉主任。 这是一个重要的论坛,项目负责人在其中交流有关项目间和项目内研究计划的信息,并提供有关每个项目中正在进行的高影响力研究的最新信息。 规划新的或修改的共享资源,招聘,跨计划合作和其他活动,以加强这些会议期间发生的方案。区域法律中心的另一项重要职责是审查加入维也纳国际中心的新申请,并向主任提出建议。会员 申请书须详细列明准会员与癌症有关的活动。RPLC评估申请是否符合VICC成员标准,然后委员会对申请人进行评审, 适合分配到适当的研究计划,并向主任提出建议,主任在任命成员方面具有最终权力。RPLC还对VICC成员进行年度审查,并评估与癌症相关的资金和出版物,计划参与和癌症 每个成员的合作。最近一次评价是在2008年秋季进行的。RPLC在CCSG试点项目申请的审查中也发挥着重要作用。RPLC为应用程序选择审阅者,并在所有审阅返回后对应用程序进行排名。这个排名过程很重要 在大多数年份,只有15 - 20%的申请能够得到资助。
英文摘要
Research Proqram Leaders Committee (RPLC) - The RPLC meets on the first Thursday of each month to discuss issues relevant to research opportunities and needs within the VICC. The meeting is co-chaired by the Director and Associate Director for Basic Science Research Programs. Other members include all Research Program Leaders and Co-Leaders, the Deputy Director, the Associate Director of Clinical Science Research Programs, the Associate Director for Prevention, Control and Population-Based Research, the Associate Director for Shared Resources, the Associate Director for CCSG Administration, and the Director Emeritus. This is an important forum in which program leaders exchange information about inter- and intra-programmatic research initiatives and provide updates about ongoing high impact research in each of the programs. Planning for new or modified shared resources, recruitments, inter-programmatic collaborations and other activities to enhance the programs occurs during these meetings. Another important charge of the RPLC is to review new requests for membership in VICC and to make recommendations to the Director. Membership applications are submitted detailing the cancer-related activities of prospective members. The RPLC evaluates the application for compliance with VICC membership criteria, the committee then judges the applicant for suitability for assignment to the appropriate research program and a recommendation is made to the Director, who has ultimate authority in appointing members. The RPLC also conducts an annual review of the VICC membership and assesses cancer-relevant funding and publications, program participation and cancer collaborations for each member. The most recent evaluation occurred in the fall of 2008. The RPLC also plays an important role in review of CCSG Pilot Project applications. The RPLC selects reviewers for the applications and ranks the applications after all reviews have been returned. This ranking process is important as most years only 15-20% of submitted applications can be funded.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Program Leaders
  • 批准号:
    8180520
  • 项目类别:
  • 资助金额:
    $19.99万
  • 财政年份:
    2010
  • 负责人:
    MARY M. ZUTTER
  • 依托单位:
Human Tissue Aquisition and Pathology Shared Resource
  • 批准号:
    8180573
  • 项目类别:
  • 资助金额:
    $24.32万
  • 财政年份:
    2010
  • 负责人:
    MARY M. ZUTTER
  • 依托单位:
The alpha2beta1 Integrin and Tumor Metastasis
  • 批准号:
    8403773
  • 项目类别:
  • 资助金额:
    $29.04万
  • 财政年份:
    2009
  • 负责人:
    MARY M. ZUTTER
  • 依托单位:
The alpha2beta1 Integrin and Tumor Metastasis
  • 批准号:
    8206619
  • 项目类别:
  • 资助金额:
    $30.9万
  • 财政年份:
    2009
  • 负责人:
    MARY M. ZUTTER
  • 依托单位:
海外基金